In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival
- PMID: 22280230
- PMCID: PMC3968956
- DOI: 10.1089/thy.2011.0121
In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival
Abstract
Background: Ultrasound (US) of the central neck compartment (CNC) is considered of limited sensitivity for nodal spread in papillary thyroid cancer (PTC); elective neck dissection is commonly advocated even in the absence of sonographic abnormalities. We hypothesized that US is an accurate predictor for long-term disease-free survival, regardless of the use of elective central neck dissection in patients with PTC.
Methods: A retrospective chart review of 331 consecutive PTC patients treated with total thyroidectomy at M.D. Anderson Cancer Center between 1996 and 2003 was performed. Information retrieved included preoperative sonographic status of the CNC, surgical treatment of the neck, demographics, cancer staging, histopathological variables and use of adjuvant treatment. The endpoints for the study were nodal recurrence and survival.
Results: There were 112 males and 219 females with a median age of 44 years (range 11-87). The median follow-up time for the series was 71.5 months (range 12.7-148.7). There were 151 (45.6%) patients with a T1, 58 (17.5%) with a T2, 70 (21.1%) with a T3, and 52 (15.7%) with a T4. Preoperative sonographic abnormalities were present in the CNC in 79 (23.9%) patients. During the surveillance period, 11 (3.2%) patients recurred in the central neck, with an average time for recurrence of 22.8 months. Advanced T stage (T3/T4) and abnormal US were independent prognostic factors for recurrence in the central neck (p=0.013 and p=0.005 respectively). There were 119 (35%) patients with a sonographically negative central compartment who underwent elective central neck dissection; 85 of them (71.4%) were found to be histopathologically N(+) while 34 (28.6%) were pN0. There were no differences in overall survival (p=0.32), disease specific survival (DSS; p=0.49), and recurrence-free survival (p=0.32) between these two groups. Preoperative US of the CNC was an age-independent predictor for overall survival (p<0.001), DSS (p=0.0097), and disease-free survival (p=0.0005) on bivariate Cox regression.
Conclusions: US of the central compartment is an age-independent predictor for survival and CNC recurrence-free survival in PTC. Prophylactic neck dissection of the central compartment does not improve long-term disease control, regardless of the histopathological status of the lymph nodes retrieved. Our findings emphasize the ability of US to clinically detect relevant nodal disease and support conservative management of the CNC in the absence of abnormal findings.
Figures



Comment in
-
Prophylactic central neck dissection in differentiated thyroid cancer: a procedure in search of an indication.Thyroid. 2012 Apr;22(4):341-3. doi: 10.1089/thy.2012.2204.ed. Thyroid. 2012. PMID: 22458971 No abstract available.
Similar articles
-
Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer.Arch Otolaryngol Head Neck Surg. 2011 Feb;137(2):157-62. doi: 10.1001/archoto.2010.254. Arch Otolaryngol Head Neck Surg. 2011. PMID: 21339402
-
Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.Surgery. 2017 Feb;161(2):465-471. doi: 10.1016/j.surg.2016.07.031. Epub 2016 Aug 26. Surgery. 2017. PMID: 27574773
-
Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma?Langenbecks Arch Surg. 2013 Mar;398(3):383-8. doi: 10.1007/s00423-012-1036-3. Epub 2012 Dec 4. Langenbecks Arch Surg. 2013. PMID: 23207498
-
Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.World J Surg Oncol. 2016 Sep 19;14(1):247. doi: 10.1186/s12957-016-1003-5. World J Surg Oncol. 2016. PMID: 27644091 Free PMC article. Review.
-
Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection.Curr Treat Options Oncol. 2012 Mar;13(1):1-10. doi: 10.1007/s11864-011-0175-z. Curr Treat Options Oncol. 2012. PMID: 22278672 Review.
Cited by
-
Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients.Cancers (Basel). 2020 Jun 23;12(6):1658. doi: 10.3390/cancers12061658. Cancers (Basel). 2020. PMID: 32585797 Free PMC article.
-
Usefulness of intraoperative determination of central lymph node metastasis by palpation in papillary thyroid cancer.Yeungnam Univ J Med. 2020 Oct;37(4):302-307. doi: 10.12701/yujm.2020.00122. Epub 2020 Apr 22. Yeungnam Univ J Med. 2020. PMID: 32316082 Free PMC article.
-
Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.World J Surg. 2018 Jan;42(1):123-129. doi: 10.1007/s00268-017-4158-5. World J Surg. 2018. PMID: 28779384
-
Guidelines from the Brazilian society of surgical oncology regarding indications and technical aspects of neck dissection in papillary, follicular, and medullary thyroid cancers.Arch Endocrinol Metab. 2023 May 12;67(4):e000607. doi: 10.20945/2359-3997000000607. Arch Endocrinol Metab. 2023. PMID: 37252696 Free PMC article.
-
Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules.J Clin Endocrinol Metab. 2024 Aug 13;109(9):2317-2324. doi: 10.1210/clinem/dgae108. J Clin Endocrinol Metab. 2024. PMID: 38415340 Free PMC article.
References
-
- Heller KS. Do all cancers need to be treated? The role of thyroglobulin in the management of thyroid cancer: the 2006 Hayes Martin lecture. Arch Otolaryngol Head Neck Surg. 2007;133:639–643. - PubMed
-
- Cooper DS. Doherty GM. Haugen BR. Kloos RT. Lee SL. Mandel SJ. Mazzaferri EL. McIver B. Sherman SI. Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–142. - PubMed
-
- Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553–559. - PubMed
-
- Lundgren CI. Hall P. Dickman PW. Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer. 2006;106:524–531. - PubMed
-
- Kupferman ME. Patterson DM. Mandel SJ. LiVolsi V. Weber RS. Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope. 2004;114:403–406. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical